Antibacterial mics of a gram-negative targeted compound collection
Ended Awarded Last action
- Contract number
- 75N93023F00001
- Awardee
-
Element Materials Technology Iowa City Inc. UEI GAJDDSFFPD89
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $236,000
Award facts
- Contract value 100% obligated
- $236,000.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- North Liberty, IA 52317, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $236,000 |
About this award
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $236,000 firm fixed-price delivery order to Element Materials Technology Iowa City Inc., doing business as JMI Laboratories, for antibacterial minimum inhibitory concentration (MIC) testing of a gram-negative targeted compound collection. The contract, which was awarded on June 12, 2023, with an ultimate completion date of June 11, 2024, will be performed in North Liberty, Iowa. This delivery order was issued under the In Vitro Assessments of Antimicrobial Activity (IVAAA) indefinite-delivery/indefinite-quantity contract vehicle, a master agreement that NIAID uses to procure specialized antimicrobial resistance testing services. No small business set-aside was applied to this award.
JMI Laboratories is a microbiology specialist company with extensive experience conducting in vitro assessments of antimicrobial activity and MIC assays in support of NIAID's antimicrobial resistance research initiatives. The company's work on this delivery order will contribute to NIAID's broader efforts to address critical public health challenges related to antimicrobial resistance by evaluating the inhibitory effects of experimental antibacterial compounds against gram-negative bacterial pathogens. JMI Laboratories' expertise in drug discovery and emerging resistance trends positions the company to provide high-quality testing data that supports the evaluation and development of new antimicrobial agents.
Quick answers
Who was awarded contract 75N93023F00001?
75N93023F00001 was awarded to Element Materials Technology Iowa City Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on June 12, 2023.
How much is contract 75N93023F00001 worth?
The government has obligated $236,000 on 75N93023F00001.
Is contract 75N93023F00001 an order under another contract?
Yes. 75N93023F00001 is a delivery order under 75N93019D00011, an indefinite delivery contract, on In Vitro Assessments of Antimicrobial Activity (IVAAA).
Was contract 75N93023F00001 competed?
The extent of competition for 75N93023F00001 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award